Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Drug Repurposing Using Metformin for Improving the Therapeutic Outcome in Multiple Sclerosis Patients

NCT05298670 is registered in ClinicalTrials.gov with German University in Cairo as lead sponsor.

NCT NCT05298670
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05298670 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Drug Repurposing Using Metformin for Improving the Therapeutic Outcome in Multiple Sclerosis Patients
Lead sponsor
German University in Cairo
Phase
Phase 2
Overall status
Unknown status
Start date
February 1, 2022
Completion date
March 28, 2023
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis